Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma × daromun × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 2 Melanoma 1 Carcinoma 1

Interventions

Cisplatin 18 Gemcitabine 12 pembrolizumab 11 Paclitaxel 11 Carboplatin 11 Fluorouracil 7 Specimen Handling 6 Sunitinib 5 Radiotherapy 5 Platinum 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Everolimus 5 Docetaxel 5 durvalumab 4 Radiotherapy, Intensity-Modulated 4 Pemetrexed 4 Oxaliplatin 4 Drug Therapy 4 Cyclophosphamide 4 Cetuximab 4 Capecitabine 4 1,2-diaminocyclohexaneplatinum II citrate 4 epothilone B 3 cemiplimab 3 atezolizumab 3 anlotinib 3 Panitumumab 3 Chemoradiotherapy 3 Celecoxib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04362722 2023-10-10

DUNCAN

Philogen S.p.A.

Phase 2 Unknown

Carcinoma, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡